Business Description
AC Immune SA is a Switzerland-based clinical-stage company focused on fighting neurodegenerative diseases by targeting the misfolded proteins that drive conditions such as Alzheimer's and Parkinson's. Its two core platforms produce both biological therapies and small-molecule drugs designed to seek out and act on these harmful proteins, supporting a broad pipeline of treatments and diagnostic tools. The company works alongside major partners including Genentech, Eli Lilly, and Janssen Pharmaceuticals to advance its programs through development.
